Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

IntroductionThe MET exon 14 skipping (METex14) mutation is an important oncogenic driver in lung cancer. We performed a retrospective analysis of clinical data from lung cancer patients with the METex14 mutation to analyze their survival outcomes and associated prognostic factors.MethodsA one-step r...

Full description

Bibliographic Details
Main Authors: Chien-Hung Gow, Min-Shu Hsieh, Yi-Lin Chen, Yi-Nan Liu, Shang-Gin Wu, Jin-Yuan Shih
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
adenocarcinoma
immunohistochemistry
MET exon 14 skipping
pulmonary sarcomatoid carcinoma
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1113696/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1113696/full

Similar Items